SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 4D Molecular Therapeutics, Inc. – FDMT
Pomerantz LLP is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. (“4D” or the “Company”)(NASDAQ: FDMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether 4D and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click […]